Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells

Journal of Experimental Medicine

Volumn 203, Issue 12, 2006, Pages 2613-2625

  Greenberg, Michael E ^a   Sun, Mingjiang ^a   Zhang, Renliang ^a   Febbraio, Maria ^a   Silverstein, Roy ^a   Hazen, Stanley L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING ASSAY; CELL DEATH; CELL MEMBRANE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; FLOW CYTOMETRY; IN VIVO STUDY; LIGAND BINDING; MACROPHAGE; MASS SPECTROMETRY; NONHUMAN; OXIDATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ANIMALS; ANTIGENS, CD36; APOPTOSIS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; HL-60 CELLS; HUMANS; JURKAT CELLS; K562 CELLS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATION-REDUCTION; PHAGOCYTOSIS; PHOSPHATIDYLSERINES;

EID: 33751519372     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20060370     Document Type: Article

References (36)

1. Henson, P.M., D.L. Bratton, and V.A. Fadok. 2001. Apoptotic cell removal. Curr. Biol. 11:R795-R805.
2. Savill, J., and V. Fadok. 2000. Corpse clearance defines the meaning of cell death. Nature. 407:784-788.
3. Meagher, L.C., J.S. Savill, A. Baker, R.W. Fuller, and C. Haslett. 1992. Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. J. Leukoc. Biol. 52:269-273.
4. Gao, Y., J.M. Herndon, H. Zhang, T.S. Griffith, and T.A. Ferguson. 1998. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J. Exp. Med. 188:887-896.
5. Endemann, G., L.W. Stanton, K.S. Madden, C.M. Bryant, R.T. White, and A.A. Protter. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268:11811-11816.
6. Rigotti, A., S.L. Acton, and M. Krieger. 1995. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J. Biol. Chem. 270:16221-16224.
7. Daviet, L., and J.L. McGregor. 1997. Vascular biology of CD36: roles of this new adhesion molecule family in different disease states. Thromb. Haemost. 78:65-69.
8. Fadok, V.A., M.L. Warner, D.L. Bratton, and P.M. Henson. 1998. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J. Immunol. 161:6250-6257.
9. Tait, J.F., and C. Smith. 1999. Phosphatidylserine receptors: role of CD36 in binding of anionic phospholipid vesicles to monocytic cells. J. Biol. Chem. 274:3048-3054.
10. Febbraio, M., D.P. Hajjar, and R.L. Silverstein. 2001. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108:785-791.
11. Savill, J., I. Dransfield, C. Gregory, and C. Haslett. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2:965-975.
12. Ren, Y., R.L. Silverstein, J. Allen, and J. Savill. 1995. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J. Exp. Med. 181:1857-1862.
13. Albert, M.L., S.F. Pearce, L.M. Francisco, B. Sauter, P. Roy, R.L. Silverstein, and N. Bhardwaj. 1998. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1359-1368.
14. Coburn, C.T., T. Hajri, A. Ibrahimi, and N.A. Abumrad. 2001. Role of CD36 in membrane transport and utilization of long-chain fatty acids by different tissues. J. Mol. Neurosci. 16:117-121.
15. Ibrahimi, A., and N.A. Abumrad. 2002. Role of CD36 in membrane transport of long-chain fatty acids. Curr. Opin. Clin. Nutr. Metab. Care. 5:139-145.
16. Jimenez, B., O.V. Volpert, S.E. Crawford, M. Febbraio, R.L. Silverstein, and N. Bouck. 2000. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med. 6:41-48.
17. Podrez, E.A., M. Febbraio, N. Sheibani, D. Schmitt, R.L. Silverstein, D.P. Hajjar, P.A. Cohen, W.A. Frazier, H.F. Hoff, and S.L. Hazen. 2000. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J. Clin. Invest. 105:1095-1108.
18. Navazo, M.D., L. Daviet, J. Savill, Y. Ren, L.L. Leung, and J.L. McGregor. 1996. Identification of a domain (155-183) on CD36 implicated in the phagocytosis of apoptotic neutrophils. J. Biol. Chem. 271:15381-15385.
19. Puente Navazo, M.D., L. Daviet, E. Ninio, and J.L. McGregor. 1996. Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL). Arterioscler. Thromb. Vasc. Biol. 16:1033-1039.
20. Pearce, S.F., P. Roy, A.C. Nicholson, D.P. Hajjar, M. Febbraio, and R.L. Silverstein. 1998. Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain. J. Biol. Chem. 273:34875-34881.
21. Febbraio, M., N.A. Abumrad, D.P. Hajjar, K. Sharma, W. Cheng, S.F. Pearce, and R.L. Silverstein. 1999. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem. 274:19055-19062.
22. Nicholson, A.C., J. Han, M. Febbraio, R.L. Silversterin, and D.P. Hajjar. 2001. Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis. Ann. N. Y. Acad. Sci. 947:224-228.
23. Podrez, E.A., E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P.J. Finton, L. Shan, M. Febbraio, D.P. Hajjar, et al. 2002. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J. Biol. Chem. 277:38517-38523.
24. Podrez, E.A., E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P.J. Finton, L. Shan, B. Gugiu, P.L. Fox, et al. 2002. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J. Biol. Chem. 277:38503-38516.
25. Ryeom, S.W., R.L. Silverstein, A. Scotto, and J.R. Sparrow. 1996. Binding of anionic phospholipids to retinal pigment epithelium may be mediated by the scavenger receptor CD36. J. Biol. Chem. 271:20536-20539.
26. Yamaguchi, A., N. Yamamoto, N. Akamatsu, T.C. Saido, M. Kaneda, M. Umeda, and K. Tanoue. 2000. PS-liposome and ox-LDL bind to different sites of the immunodominant domain (#155-183) of CD36: a study with GS95, a new anti-CD36 monoclonal antibody. Thromb. Res. 97:317-326.
27. Kagan, V.E., B. Gleiss, Y.Y. Tyurina, V.A. Tyurin, C. Elenstrom-Magnusson, S.X. Liu, F.B. Serinkan, A. Arroyo, J. Chandra, S. Orrenius, and B. Fadeel. 2002. A role for oxidative stress in apoptosis: oxidation and externalization of phosphatidylserine is required for macrophage clearance of cells undergoing Fas-mediated apoptosis. J. Immunol. 169:487-499.
28. Pulfer, M., and R.C. Murphy. 2003. Electrospray mass spectrometry of phospholipids. Mass Spectrom. Rev. 22:332-364.
29. Fadok, V.A., A. de Cathelineau, D.L. Daleke, P.M. Henson, and D.L. Bratton. 2001. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J. Biol. Chem. 276:1071-1077.
30. Bose, J., A.D. Gruber, L. Helming, S. Schiebe, I. Wegener, M. Hafner, M. Beales, F. Kontgen, and A. Lengeling. 2004. The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal. J. Biol. 3:15.
31. Williamson, P., and R.A. Schlegel. 2004. Hide and seek: the secret identity of the phosphatidylserine receptor. J. Biol. 3:14.
32. Finnemann, S.C., and R.L. Silverstein. 2001. Differential roles of CD36 and αvβ5 integrin in photoreceptor phagocytosis by the retinal pigment epithelium. J. Exp. Med. 194:1289-1298.
33. Greenberg, M.E., A.J. Iafrate, and J. Skowronski. 1998. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J. 17:2777-2789.
34. Podrez, E.A., D. Schmitt, H.F. Hoff, and S.L. Hazen. 1999. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J. Clin. Invest. 103:1547-1560.
35. Henson, P.M., B. Zanolari, N.A. Schwartzman, and S.R. Hong. 1978. Intracellular control of human neutrophil secretion. I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B. J. Immunol. 121:851-855.35.
36. Bligh, E.G., and W.J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.